Minnesota Board of Pharmacy: Manufacturers Must Be Tracking 2014 Payments to PAs and Nurse Practitioners; Reports Due May 1, 2015

  We recently reported that Minnesota had updated its statute to require manufacturers report their payments to physician assistants, nurse practitioners, veterinarians, and dental therapists. On July 9, the Minnesota Board of Pharmacy released a memo to clarify their position on manufacturers’ duties in light of the federal Physician Payments Sunshine Act. “As you may know, during the 2013 Session of the Minnesota Legislature, the Minnesota Board of Pharmacy sought the repeal of a provision in Minnesota Statutes §151.47, subd. 1(f) that required pharmaceutical manufacturers to report certain payments made to practitioners. The Board sought that repeal due to the fact that a relatively new federal statute pre-empts states from collecting data about payments made to physicians.  Most of the data that the Board had been collecting involves payments made to "physicians" - which is defined in the federal law to include physicians, dentists, optometrists and podiatrists.  “The legislature did not pass a full repeal of the reporting requirement.  Instead, they modified the requirement as follows:  Subd. 3. Payment to practitioner; reporting. Unless prohibited by United States Code, title 42, section 1320a-7h, a drug manufacturer shall file with the board an annual report, in a form and on the date prescribed by the board, identifying all payments, honoraria, reimbursement, or other compensation authorized under section 151.461, clauses (4) an...
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs